N-(4-(4-methylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-4-(pyridin-4-yl)pyrimidin-2-amine

ID: ALA5316225

Chembl Id: CHEMBL5316225

Max Phase: Preclinical

Molecular Formula: C37H50O16

Molecular Weight: 750.79

Associated Items:

Names and Identifiers

Canonical SMILES:  C[C@@H]1[C@@H](C)[C@H](C)O[C@@H](O[C@@H]2[C@@H](O)[C@H](OCCc3ccc(O)c(O)c3)O[C@H](CO[C@@H]3OC[C@](O)(CO)[C@H]3O)[C@H]2OC(=O)/C=C/c2ccc(O)c(O)c2)[C@@H]1C

Standard InChI:  InChI=1S/C37H50O16/c1-18-19(2)21(4)50-34(20(18)3)53-32-30(44)35(47-12-11-23-6-9-25(40)27(42)14-23)51-28(15-48-36-33(45)37(46,16-38)17-49-36)31(32)52-29(43)10-7-22-5-8-24(39)26(41)13-22/h5-10,13-14,18-21,28,30-36,38-42,44-46H,11-12,15-17H2,1-4H3/b10-7+/t18-,19-,20-,21+,28-,30-,31-,32-,33+,34+,35-,36-,37-/m1/s1

Standard InChI Key:  OBJQKPXLHQUYSF-GMDSVFOVSA-N

Alternative Forms

  1. Parent:

    ALA5316225

    ---

Associated Targets(Human)

CDK2 Tchem Cyclin-dependent kinase 2/cyclin A (2220 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
THP-1 (11052 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BCHE Tclin Butyrylcholinesterase (7174 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

pknB Serine/threonine-protein kinase pknB (356 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mycobacterium tuberculosis (203094 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 750.79Molecular Weight (Monoisotopic): 750.3099AlogP: 1.27#Rotatable Bonds: 13
Polar Surface Area: 243.52Molecular Species: NEUTRALHBA: 16HBD: 8
#RO5 Violations: 3HBA (Lipinski): 16HBD (Lipinski): 8#RO5 Violations (Lipinski): 3
CX Acidic pKa: 9.01CX Basic pKa: CX LogP: 3.36CX LogD: 3.35
Aromatic Rings: 2Heavy Atoms: 53QED Weighted: 0.08Np Likeness Score: 1.80

References

1. Wlodarchak N, Feltenberger JB, Ye Z, Beczkiewicz J, Procknow R, Yan G, King TM, Golden JE, Striker R..  (2021)  Engineering Selectivity for Reduced Toxicity of Bacterial Kinase Inhibitors Using Structure-Guided Medicinal Chemistry.,  12  (2.0): [PMID:35035774] [10.1021/acsmedchemlett.0c00580]
2. Lopes JPB, Silva L, Lüdtke DS..  (2021)  An overview on the synthesis of carbohydrate-based molecules with biological activity related to neurodegenerative diseases.,  12  (12.0): [PMID:35028560] [10.1039/D1MD00217A]

Source